A new section of the second Sichuan-to-East natural gas pipeline, a key energy infrastructure project in China, began ...

Tempus AI and Hims & Hers are riding healthcare IT growth, but diagnostics scale and consumer demand set different upside paths.

Get the latest analysis on Regencell Bioscience (RGC): liquidity risks, DOJ investigation, and lack of revenue.

University of Pennsylvania researcher Ran Barzilay is a father of three. His first two children received cellphones before ...

In this article, we will discuss: 12 Best Genomics Stocks to Invest In. Companies that study DNA to improve people’s lives ...

From immune cell therapies to measles outbreaks to federal attacks on public health, these are some of the health topics ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

The Harbor Emerging Markets Select ETF underperformed its benchmark despite strong gains in Chinese technology holdings.

Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...